Department of Gastroenterology, General Hospital, Sanremo, Italy.
Gastrointest Endosc. 2012 Dec;76(6):1160-9. doi: 10.1016/j.gie.2012.08.009. Epub 2012 Sep 26.
EMR is an effective alternative to surgery for the removal of nonampullary duodenal polyps (NADPs). Cap-assisted EMR (EMR-C) has been rarely performed in the duodenum because of the risk of perforation.
To evaluate the safety and effectiveness of EMR-C for the removal of large (≥ 15 mm) NADPs.
Retrospective study.
Tertiary-care referral center.
Between 2000 and 2010, 26 consecutive patients with sporadic NADPs underwent EMR-C.
EMR with the cap technique.
Complete eradication of polyps, complications, and recurrence.
A total of 14 sessile polyps (53.8%), 7 lateral spreading type nongranular tumors (26.9%), and 5 lateral spreading type granular tumors (19.2%) were treated. The median size of lesions was 15 mm. Five lesions involved one-half of the luminal circumference. Post-EMR histologic assessment showed low-grade dysplasia in 5 patients (19.2%) and high-grade dysplasia in 18 patients (69.2%). Three patients (11.5%) had well-differentiated endocrine tumors. Complete eradication was obtained in 25 of 26 (96%) patients. No perforations occurred. Three cases of intraprocedural bleeding were managed endoscopically. Median follow-up was 6 years (range 1-10 years). Residual adenomatous tissue was observed in 3 patients in lesions of 50 mm. In one of these cases, an adenocarcinoma occurred after 8 months, which was managed surgically.
Retrospective design, single center.
This study supports the efficacy and safety of EMR-C for removing NADPs. Regular follow-up is mandatory because of the high risk of residual or recurrent adenomatous tissue and even cancer.
内镜下黏膜切除术(EMR)是一种有效替代手术切除十二指肠非壶腹型息肉(NADP)的方法。由于穿孔的风险,在十二指肠中很少使用帽式辅助 EMR(EMR-C)。
评估 EMR-C 切除大(≥ 15mm)NADP 的安全性和有效性。
回顾性研究。
三级转诊中心。
2000 年至 2010 年期间,26 例散发性 NADP 患者接受 EMR-C 治疗。
帽式 EMR 技术。
息肉完全消除、并发症和复发情况。
共治疗 14 个无蒂息肉(53.8%)、7 个侧向扩展型非颗粒状肿瘤(26.9%)和 5 个侧向扩展型颗粒状肿瘤(19.2%)。病变的中位大小为 15mm,5 个病变累及半圈管腔。EMR 后组织学评估显示 5 例(19.2%)为低级别异型增生,18 例(69.2%)为高级别异型增生。3 例(11.5%)为分化良好的内分泌肿瘤。26 例患者中的 25 例(96%)完全消除了病变。无穿孔发生。3 例术中出血通过内镜治疗。中位随访时间为 6 年(1-10 年)。在 50mm 的病变中,3 例患者观察到残留腺瘤组织。其中 1 例在 8 个月后发生腺癌,行手术治疗。
回顾性设计,单中心。
本研究支持 EMR-C 切除 NADP 的疗效和安全性。由于残留或复发性腺瘤组织甚至癌症的高风险,必须进行定期随访。